Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab + bendamustine for relapsed/refractory indolent lymphomas
2012-005338-13Phase 2Terminated
- Sponsor
- Humanitas Research Hospital
- Start
- Jun 2013
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab, bendamustine in follicular lymphoma (FL), non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by Humanitas Research Hospital. Started Jun 2013; status: terminated.
02
Drugs
ofatumumabbendamustine
03
Conditions
follicular lymphoma (FL)non-Hodgkin lymphoma (NHL)chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2012-005338-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005338-13.